Trump lansează o enormă provocare strategică: medicamentele generice. Proiectul european în domeniu depinde de nivelul ambițiilor naționale

Trump's strategic challenge focuses on generic drugs, urging the U.S. to relocate production domestically. This move raises concerns for Europe, heavily reliant on Asian imports for essential medicines. The EU is working on legislation to address shortages of critical drugs, but national priorities may hinder progress. The need for increased production capacity in Europe is evident, yet investment in pharmaceuticals remains low compared to military spending.